Primaquine Clears Malaria Gametocytes After Treatment
Author Information
Author(s): Shekalaghe Seif, Drakeley Chris, Gosling Roly, Ndaro Arnold, van Meegeren Monique, Enevold Anders, Alifrangis Michael, Mosha Frank, Sauerwein Robert, Bousema Teun
Primary Institution: Radboud University Nijmegen Medical Centre
Hypothesis
Does the addition of primaquine to standard malaria treatment effectively clear submicroscopic Plasmodium falciparum gametocytes?
Conclusion
Primaquine effectively clears submicroscopic gametocytes after treatment with sulphadoxine-pyrimethamine and artesunate, reducing the potential for malaria transmission.
Supporting Evidence
- Only 3.9% of children treated with SP+AS+PQ had gametocytes on day 14 after treatment.
- Gametocyte prevalence and density were significantly lower in children treated with SP+AS+PQ.
- Haemoglobin levels recovered to pre-treatment levels within one month after treatment.
- Children with G6PD deficiency showed a transient reduction in haemoglobin levels after treatment with primaquine.
Takeaway
This study shows that giving primaquine along with malaria treatment helps get rid of tiny malaria germs that can still spread the disease, making it safer for everyone.
Methodology
Children aged 3–15 years with uncomplicated malaria were randomized to receive either standard treatment or standard treatment plus primaquine, with follow-up for gametocyte prevalence and density.
Potential Biases
Potential bias in treatment allocation and participant selection due to the study physician's involvement in both.
Limitations
The study did not directly measure post-treatment malaria transmission and focused primarily on the first two weeks after treatment.
Participant Demographics
Children aged 3–15 years from a rural village in north-eastern Tanzania.
Statistical Information
P-Value
0.004
Confidence Interval
95% CI = 0.049–0.57
Statistical Significance
p<0.001
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website